ulcerative colitis glp-1 Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology The Potential for GLP-1s in
Description
Find your match!
Some of the drug's trial results were about on par with weight loss from gastric bypass surgery.
Here authors report the cryo-EM structure of GLP-1R bound to an ago-allosteric modulator in complex with heterotrimeric Gs which offers insights into the molecular details of ago-allosterism.
The second study analyzed the effect of a monoclonal antibody that inhibits muscle mass loss, but found limited benefit
